LA SR217 | 2021 | Regular Session

Status

Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Passed on June 10 2021 - 100% progression
Action: 2021-06-10 - Enrolled. Signed by the President of the Senate and sent to the Secretary of State by the Secretary of the Senate on 6/14/2021.
Text: Latest bill text (Enrolled) [PDF]

Summary

Directs the Louisiana Department of Health and the LSU Health Services Center - New Orleans, health care services division, to report on the use and results of hydroxychloroquine on Medicaid patients for treating COVID-19.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Directs the Louisiana Department of Health and the LSU Health Services Center - New Orleans, health care services division, to report on the use and results of hydroxychloroquine on Medicaid patients for treating COVID-19.

Sponsors


Roll Calls

2021-06-10 - Senate - Senate Vote on SR 217 ADOPT (#1123) (Y: 22 N: 13 NV: 0 Abs: 3) [PASS]

History

DateChamberAction
2021-06-10SenateEnrolled. Signed by the President of the Senate and sent to the Secretary of State by the Secretary of the Senate on 6/14/2021.
2021-06-10SenateBy a vote of 22 yeas and 13 nays.
2021-06-10SenateSenate amendments read and adopted. Read by title and adopted.
2021-06-09SenateRules suspended. Introduced in the Senate. Read by title and placed on the Calendar for a second reading.

Subjects


Louisiana State Sources


Bill Comments

feedback